claudin- hepatitis c virus co-receptor required late step entry 
hepatitis c virus hcv leading cause cirrhosis liver cancer worldwide better understanding viral life cycle including mechanisms entry host cells needed identify novel therapeutic targets although hcv entry requires cd81 co-receptor host molecules implicated least one factor critical process remains unknown reviewed refs using iterative expression cloning approach identified claudin- cldn1 tight junction component highly expressed liver4 essential hcv entry cldn1 required hcv infection human hepatoma cell lines first factor confer susceptibility hcv ectopically expressed non-hepatic cells discrete residues within first extracellular loop el1 cldn1 protein interaction motifs intracellular domains critical hcv entry moreover antibodies directed epitope inserted cldn1 el1 block hcv infection kinetics inhibition indicate cldn1 acts late entry process virus binding interaction hcv co-receptor cd81 cldn1 identified novel key factor hcv entry new target antiviral drug development 
